Trial intelligence / Profile preview

Perioperative low-dose aspirin for secondary prevention of postoperative ischemic events in intermediate-risk elective surgery

2007-006875-35Phase 4Active

Sponsor
IMAS
Start
Oct 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of aspirin in cardiac morbidity (2 arms), sponsored by IMAS. Primary endpoints: Postoperative cardiovascular complications and Postoperative morbidity and mortality. Started Oct 2009; status: active.

02

Drugs

aspirin
03

Conditions

cardiac morbidity

Beyond the preview

Go deeper on 2007-006875-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-006875-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call